TaiwanJ Pharmaceuticals Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 0 compared to TWD 61.720 million a year ago. Operating loss was TWD 40.378 million compared to TWD 6.688 million a year ago. Net loss was TWD 42.457 million compared to TWD 5.083 million a year ago. Basic loss per share from continuing operations was TWD 0.6 compared to TWD 0.07 a year ago.